Search - tctmd.com

Displaying 1 - 20 of 25

Sort: Relevancy | Date

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

Presentation TCT 2023

Rotational atherectomy combined with cutting balloon to optimize stent expansion in calcified lesions – Primary Results of the ROTACUT trial

Presenter: Samin Sharma

October 23, 2023

Presentation TCT 2022

TCT 167: Percutaneous Coronary Intervention with Ultrathin-Strut Biodegradable versus Thin-Strut Durable Polymer Drug-Eluting Stents of Lesions Requiring Multiple Stents: A Lesion-Level Subgroup Analysis of the Combined BIOSCIENCE and BIOSTEMI Randomized…

Presenter: Jonas Haener

September 19, 2022

News Conference News TCT 2022

Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL

Yael L. Maxwell

September 19, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

News Conference News TCT 2021

More DAPT Duration Data, More Calls to Tailor to Individual Patients

Shelley Wood

November 05, 2021

News Conference News TCT 2021

NSTEMI Patients With CKD See Better Outcomes With Invasive Strategy

L.A. McKeown

October 22, 2021

News Conference News TCT 2020

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

Michael O'Riordan

October 14, 2020

Presentation TCT 2020

TCT 281: Clinical Outcomes of Optical Coherence Tomography Detected High Risk Versus Low Risk Coronary Atherosclerotic Lesions in Medically Treated Fractional Flow Reserve Negative Lesions in Diabetes Mellitus Patients. The COMBINE Trial.

Presenter: Elvin Kedhi

October 14, 2020

News Conference News TCT 2019

TICAKOREA: Ticagrelor Ups Bleeding Over Clopidogrel in Korean ACS Patients

Todd Neale

October 03, 2019

News Conference News TCT 2019

FORZA: For Intermediate Lesions, OCT-Guided PCI Costs More, Yields Better Outcomes vs FFR

Caitlin E. Cox

October 01, 2019

Presentation TCT 2019

The ABILITY DIABETES Global Trial: The Largest Randomized Control Trial With Coronary Stents for the Diabetic Population

Presenter: Antonio Colombo

September 28, 2019

Presentation TCT 2019

The ABILITY DIABETES GLOBAL Imaging Study (Randomized Control Trial Comparing Abluminus DES vs. Xience)

Presenter: Azeem Latib

September 28, 2019

News TCT 2019

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

Shelley Wood

September 26, 2019

News Conference News TCT 2019

AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups

Todd Neale

September 26, 2019

News Conference News TCT 2019

Onyx ONE: Shorter DAPT Plus ZES Noninferior to Polymer-Free Stent in High-Bleeding-Risk Patients

L.A. McKeown

September 26, 2019

News Conference News TCT 2019

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Yael L. Maxwell

September 26, 2019

News Conference News TCT 2018

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

Michael O'Riordan

October 02, 2018

News Conference News TCT 2018

OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients

Todd Neale

September 24, 2018

News Opinion Off Script TCT 2017

Off Script: Connecting and Collaborating in the Global Village of Interventional Cardiology

Kwan S. Lee

November 01, 2017

Advertisement

What’s Going to Be Big at TCT 2024?

Rotational atherectomy combined with cutting balloon to optimize stent expansion in calcified lesions – Primary Results of the ROTACUT trial

TCT 167: Percutaneous Coronary Intervention with Ultrathin-Strut Biodegradable versus Thin-Strut Durable Polymer Drug-Eluting Stents of Lesions Requiring Multiple Stents: A Lesion-Level Subgroup Analysis of the Combined BIOSCIENCE and BIOSTEMI Randomized…

Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL

New Faces, New Formats, New Tech: What to Expect From TCT 2022

More DAPT Duration Data, More Calls to Tailor to Individual Patients

NSTEMI Patients With CKD See Better Outcomes With Invasive Strategy

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

TCT 281: Clinical Outcomes of Optical Coherence Tomography Detected High Risk Versus Low Risk Coronary Atherosclerotic Lesions in Medically Treated Fractional Flow Reserve Negative Lesions in Diabetes Mellitus Patients. The COMBINE Trial.

TICAKOREA: Ticagrelor Ups Bleeding Over Clopidogrel in Korean ACS Patients

FORZA: For Intermediate Lesions, OCT-Guided PCI Costs More, Yields Better Outcomes vs FFR

The ABILITY DIABETES Global Trial: The Largest Randomized Control Trial With Coronary Stents for the Diabetic Population

The ABILITY DIABETES GLOBAL Imaging Study (Randomized Control Trial Comparing Abluminus DES vs. Xience)

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups

Onyx ONE: Shorter DAPT Plus ZES Noninferior to Polymer-Free Stent in High-Bleeding-Risk Patients

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients

Off Script: Connecting and Collaborating in the Global Village of Interventional Cardiology

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content